Tryptamine Therapeutics ( ($AU:ENP) ) just unveiled an update. Entropy Neurodynamics Limited has notified the market of the issue of 2 million ...

Entropy Neurodynamics Limited has successfully completed the first patient dosing in its clinical trial for treating Binge Eating Disorder using TRP-8803, an IV-infused psilocin. This trial aims to ...

Our mission is to support our patients with mental or neurological disorders from the initial diagnostic to the end of the intervention, offering them state of the art technology to evaluate and treat ...

Special Report: Entropy Neurodynamics has completed dosing of its IV-infused psilocin TRP-8803 for the first patient ...

Trailing total returns as of 12/23/2025, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] (^AXJO) Return TYPTF S&P/ASX 200 [XJO] (^AXJO) ...

Dr. Adil Dalal, DBA - CEO, keynote speaker, leadership and AI pioneer. Author of 4 books and 10 global awards, inspiring leaders worldwide. The explosive growth of artificial intelligence (AI) is ...

Visit a quote page and your recently viewed tickers will be displayed here.